S. 2465 became law 293 days after introduction, with cosponsors from both parties
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
Written by the Congressional Research Service [2]. 91 words.
Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2018
(Sec. 2) This bill amends the Public Health Service Act to authorize the Department of Health and Human Services to award grants to government, educational, and nonprofit entities for the purpose of supporting data collection and public health activities regarding heritable blood disorders, including sickle cell disease.
(Sec. 3) Additionally, the bill reauthorizes through FY2023 and revises the sickle cell disease grant program for federally-qualified health centers, nonprofit hospitals or clinics, and university health centers.
- Committees
- Senate Health, Education, Labor, and Pensions Committee
- Policy area
- Health: 122 of 9,357 bills became law, 113th–118th (1.3%)
- Sponsor
- 5 of 220 bills enacted since 2013
- Text versions
- 5, from enrolled bill to public law · 1,163 words
- Subjects
- Blood and blood diseasesHealth care coverage and accessHealth information and medical recordsHealth programs administration and fundingHealth promotion and preventive careMedical research +3 more
- Latest action
- Dec 18, 2018: Became Public Law No: 115-327.
- Records
- Congress.gov · Bill text
Each bill appears once, under its strongest link. 3 in all.
Related, per CRS or House · 3
- 115th H.R. 2410 Sickle Cell Disease Research, Surveillance, Prevention, and Treatment Act of 2017 D · Passed one chamber
- 115th H.R. 5942 Health Equity and Accountability Act of 2018 D · Introduced
- 115th S. 3660 Health Equity and Accountability Act of 2018 D · Introduced